Recalls & Alerts Published by NAFDAC

The National Agency for Food and Drug Administration and Control has been notified of the voluntary recall of one lot of 50% Magnesium Sulphate Injection, USP, 10g/20ml (0.5g/ml), 20ml single dose vials by Hospira, Inc., a Pfizer subsidiary company due to the presence of particulate matter. Particulate matter was confirmed to contain high out of specification result for pH in one single dose fliptop vial.

Magnesium sulphate injection is indicated for replacement therapy in magnesium deficiency especially in acute hypomagnesemia. It is also used for the prevention and control of seizures in pre-eclampsia and eclampsia.

The patient will likely be unharmed if the particulate is detected prior to dispensing or administration. If therapy is delayed however, it may lead to potentially serious medical consequences for the mother and foetus requiring serious medical intervention. If not detected prior to administration, localized swelling, redness, injection site pain, allergic reactions, microembolic effects and possible foetal harm may occur.

Product details

  • Lot number:50-343-DK
  • Expiration Date: 01/02/2017
  • NDC 0409-2168-02

Healthcare Provider’s Action

  • Healthcare providers should discontinue the use and distribution of any existing inventory of the product and quarantine the product
  • Report all serious adverse events or side effects related to the use of this product to NAFDAC PRASCOR (20543 – Toll free from all network) or via individual case safety report forms or to This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC… Safeguarding the health of the Nation!!!

Tuesday, 17 May 2016 08:01

Recall On Bumble Bee Canned Tuna

The Agency has been notified of Bumble Bee Foods, LLC, San Diego, California recall on three batches of its 5 oz. canned tuna products due to possible contamination by spoilage organisms or pathogens. Bumble bee detected improper sterilization processes of materials used in packaging by a facility not owned or operated by Bumble Bee.

This recall is being initiated out of an abundance of caution due to the possible under-processing of the affected products discovered by the co-pack facility during its routine quality audit.

All recalled tuna cans are marked with a can code that starts with ‘T’, and has the following “best by” dates below;

Product details

Label UPC Product "Best By" Dates" Can Codes  
8660000020 5oz Bumble Bee Chunk
Light Tuna in Water
02/10/2019, 02/16/2019, 02/17/2019, 02/18/2019,
02/22/2019, 02/23/2019, 02/25/2019
TOA2BSCAFB, TOA3BSCAFB,  TOA4BSCAFB, TOA5BSCAFB, TOABBSCAFB, TOACBSCAFB, TOADBSCAFB, TOAEBSCAFB, TOG3BSCAFB, TOG4BSCAFB, TOH6BSCAFB, TOH7BSCAFB, TOHABSCAFB, TOHBBSCAFB, TOHCBSCAFB,
8660000021 5oz Bumble Bee Chunk
Light Tuna in Oil
02/23/2019 TOODGSCEFB
8660000736 4 Pack of 5oz Bumble Bee
Chunk Light Tuna in
Water
02/9/2019, 02/10/2019, 02/22/2019, 02/29/2019 TO9BBSCAFB, TO9DBSCAFB, TOA2BSCAFB, TON2BSCAFB, TON4BSCAFB, TON8BSCAFB, TONBBSCAFB, TONDBSCAFB, TONFBSCAFB,

The Agency is warning that consuming specific cans of Chunk Light Tuna in Water and Chunk Light Tuna in Vegetable Oil produced in February 2015 could lead to serious illness. It is important to note that no reports of illness have been linked to the recall

NAFDAC is urging any consumer or supplier with a product that fits the above specifications to throw it away.

Report all serious adverse events or side effects related to the use of these products to NAFDAC PRASCOR (20543 – Toll free from all network) or via adverse events report forms or to This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC… Safeguarding the health of the Nation!!!

The Agency has been notified of the recall of four batches of Cinnarizine Tablet 25mg by the manufacturer, Industrial Fermaceutica Nova Argentia Spa, Italy. The recall is as a result of received complaints about black spots found on certain Cinnarizine tablets. The black spots were suspected to be foreign matter including plastic fragments and lubricant. The Italian manufacturer decided to recall four affected batches from the market after preliminary investigation.

Cinnarizine is an over-the-counter medication used in the treatment of motion sickness, nausea and vomiting.

Product details

  • Manufacturer: Industrial Fermaceutica Nova Argentia Spa, Italy.
  • Drug name: Cinnarizine tablets 25mg
  • Registration number: HK-12005
  • Batch numbers: M40594/1, M40594/2, 150282/1 and 150282/2

Healthcare Provider/Patient’s action

  • Healthcare providers should desist from administering Cinnarizine that fits the above specifications to patients.
  • Report all serious adverse events or side effects related to the use of these drug products to NAFDAC PRASCOR (20543 – Toll free from all network) or via adverse events report forms or to This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC… Safeguarding the health of the Nation!!!

Page 2 of 4

CORPORATE LINKS